To clarify whether antibody-based Tie2 activation and VEGFR2 blockade can normalize tumor vessels in spontaneous GBM models, we examined the morphology of EGFRVIII GBM tumor vessels after treatment with IgG, 4E2, or DC101. This evidence concerns the gene TEK and glioblastoma.